XIAP and ovarian carcinoma: miR-509-3p directly targets XIAP to inhibit proliferation [11], and targets XIAP, Golgi phosphoprotein-3 (GOLPH3), and Wnt ligand secretion mediator (WLS) [9] to regulate platinum sensitivity in chemoresistant ovarian cancer cells.